Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
By contrast, lower doses like 4 mg still produced meaningful loss, often in the low double-digit percentage range, though not to the same magnitude
Risk factor control and cardiovascular event risk in people with type 2 diabetes in primary and secondary prevention settings
Your healthcare team can help guide you through the transition process
Tirzepatide is a dual GLP-1/GIP receptor agonist
Not for diagnostic, therapeutic, or veterinary purposes
The drug was approved in 2019 and is typically taken in 7- or 14-milligram doses
US$ 22.85
US$ 28.63
US$ 23.19
US$ 21.78
